|Systematic (IUPAC) name|
|Legal status||Analogue of MDMA (AU) Analogue of amphetamine (CA) Temporary class drug (UK) Analogue of MDMA (US)|
6-MAPB (1-(benzofuran-6-yl)-N-methylpropan-2-amine) is a presumably entactogenic drug which is structurally related to 6-APB and MDMA. It is not known to have been widely sold as a "designer drug" but has been detected in analytical samples taken from individuals hospitalised after using drug combinations that included other benzofuran derivatives. 6-MAPB was banned in the UK in June 2013, along with 9 other related compounds which were thought to produce similar effects.
- "Temporary class drug order report on 5-6APB and NBOMe compounds". UK Home Office. 4 Jun 2013. Retrieved 2013-07-10.